Aspira Women's Health Files 8-K

TL;DR

Aspira Women's Health updated its principal executive office address in an 8-K filing.

AI Summary

On October 14, 2025, Aspira Women's Health Inc. filed an 8-K report. The filing indicates that the company's principal executive offices are located at 12117 Bee Caves Road, Building III, Suite 100, Austin, TX 78738. This report is a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Why It Matters

This 8-K filing provides an update on the company's principal executive office location, which is important for investors and stakeholders to know for official correspondence and potential site visits.

Risk Assessment

Risk Level: low — The filing is a routine administrative update regarding the company's office location and does not contain significant financial or operational news.

Key Players & Entities

• Aspira Women's Health Inc. (company) — Registrant
• October 14, 2025 (date) — Date of earliest event reported
• 12117 Bee Caves Road, Building III, Suite 100, Austin, TX 78738 (location) — Principal executive offices address
• Securities Exchange Act of 1934 (legal_document) — Governing act for the filing

FAQ

From the Filing

0001493152-25-018146.txt : 20251015 0001493152-25-018146.hdr.sgml : 20251015 20251015161544 ACCESSION NUMBER: 0001493152-25-018146 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20251014 ITEM INFORMATION: Other Events FILED AS OF DATE: 20251015 DATE AS OF CHANGE: 20251015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 251394996 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 8-K 1 form8-k.htm 8-K false 0000926617 0000926617 2025-10-14 2025-10-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): October 14, 2025   ASPIRA WOMEN’S HEALTH INC. (Exact name of registrant as specified in its charter)   Delaware   001-34810   33-0595156 (State or other jurisdiction of   (Commission   (IRS Employer incorporation or organization)   File Number)   Identification No.)   12117 Bee Caves Road , Building III , Suite 100 Austin , TX 78738 (Address of principal executive office) (Zip Code)   (512) 519-0400 (Registrants’ telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.001   AWHL   OTCQX   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)   Emerging Growth Company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 8.01 Other Events.   On October 14, 2025, Aspira Women’s Health Inc. upgraded to OTCQX from the OTCQB® Venture Market. Aspira Women’s Health Inc. trades on OTCQX under the symbol “AWHL.”         SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by t